The New Face of Hyperlipidemia and the Role of PCSK9 Inhibitors

Nicholls, SJ

Nicholls, SJ (reprint author), Univ Adelaide, South Australian Hlth & Med Res Inst, POB 11050, Adelaide, SA 5001, Australia.

CURRENT CARDIOLOGY REPORTS, 2019; 21 (4):

Abstract

Purpose of ReviewTo review the clinical rationale for use of proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors in clinical practice.Rec......

Full Text Link